title: Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy.
authors.affiliation: Institut für Pharmakologie, Universität zu Köln, Klinische Pharmakologie, Germany. stefanwilde@hotmail.com
authors.forename: S
authors.initials: S
authors.lastname: Wilde
authors.forename: A
authors.initials: A
authors.lastname: Jetter
authors.forename: M
authors.initials: M
authors.lastname: Zaigier
authors.forename: S
authors.initials: S
authors.lastname: Rietbrock
authors.forename: H
authors.initials: H
authors.lastname: Menzel
authors.forename: M
authors.initials: M
authors.lastname: Sieber
authors.forename: H
authors.initials: H
authors.lastname: Tesch
authors.forename: G
authors.initials: G
authors.lastname: Hempel
authors.forename: D
authors.initials: D
authors.lastname: Busse
authors.forename: M
authors.initials: M
authors.lastname: Schwab
authors.forename: S
authors.initials: S
authors.lastname: Reif
authors.forename: U
authors.initials: U
authors.lastname: Jaehde
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.forename: U
authors.initials: U
authors.lastname: Fuhr
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D003520:Cyclophosphamide / Q000097:blood / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000097:blood / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005047:Etoposide / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological
chemical_list: D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide